AAAAAA

   
Results: 1-6 |
Results: 6

Authors: FEIGHNER SD HOWARD AD PRENDERGAST K PALYHA OC HRENIUK DL NARGUND R UNDERWOOD D TATA JR DEAN DC TAN CP MCKEE KK WOODS JW PATCHETT AA SMITH RG VANDERPLOEG LHT
Citation: Sd. Feighner et al., STRUCTURAL REQUIREMENTS FOR THE ACTIVATION OF THE HUMAN GROWTH-HORMONE SECRETAGOGUE RECEPTOR BY PEPTIDE AND NONPEPTIDE SECRETAGOGUES, Molecular endocrinology, 12(1), 1998, pp. 137-145

Authors: HRENIUK D HOWARD A WOODS J PALYHA O DASHKEVICZ M NARGUND R SMITH R VANDERPLOEG LHT FEIGHNER S
Citation: D. Hreniuk et al., CYTOCHEMICAL IDENTIFICATION AND CLONING OF A G-PROTEIN-COUPLED GROWTH-HORMONE SECRETAGOGUE RECEPTOR, The FASEB journal, 11(3), 1997, pp. 2278-2278

Authors: LIEBER RL JACKS TM MOHLER RL SCHLEIM K HAVEN M CUIZON D GERSHUNI DH LOPEZ MA HORA D NARGUND R FEENEY W HICKEY GJ
Citation: Rl. Lieber et al., GROWTH-HORMONE SECRETAGOGUE INCREASES MUSCLE STRENGTH DURING REMOBILIZATION AFTER CANINE HINDLIMB IMMOBILIZATION, Journal of orthopaedic research, 15(4), 1997, pp. 519-527

Authors: HOWARD AD FEIGHNER SD CULLY DF ARENA JP LIBERATOR PA ROSENBLUM CI HAMELIN M HRENIUK DL PALYHA OC ANDERSON J PARESS PS DIAZ C CHOU M LIU KK MCKEE KK PONG SS CHAUNG LY ELBRECHT A DASHKEVICZ M HEAVENS R RIGBY M SIRINATHSINGHJI DJS DEAN DC MELILLO DG PATCHETT AA NARGUND R GRIFFIN PR DEMARTINO JA GUPTA SK SCHAEFFER JM SMITH RG VANDERPLOEG LHT
Citation: Ad. Howard et al., A RECEPTOR IN PITUITARY AND HYPOTHALAMUS THAT FUNCTIONS IN GROWTH-HORMONE RELEASE, Science, 273(5277), 1996, pp. 974-977

Authors: JACKS T SMITH R JUDITH F SCHLEIM K FRAZIER E CHEN H KRUPA D HORA D NARGUND R PATCHETT A HICKEY G
Citation: T. Jacks et al., MK-0677, A POTENT, NOVEL, ORALLY-ACTIVE GROWTH-HORMONE (GH) SECRETAGOGUE - GH, INSULIN-LIKE GROWTH-FACTOR-I, AND OTHER HORMONAL RESPONSES IN BEAGLES, Endocrinology, 137(12), 1996, pp. 5284-5289

Authors: CHANG CH RICKES EL MCGUIRE L FRAZIER E CHEN H BARAKAT K NARGUND R PATCHETT A SMITH RG HICKEY GJ
Citation: Ch. Chang et al., GROWTH-HORMONE (GH) AND INSULIN-LIKE GROWTH-FACTOR-I RESPONSES AFTER TREATMENTS WITH AN ORALLY-ACTIVE GH SECRETAGOGUE L-163,255 IN SWINE, Endocrinology, 137(11), 1996, pp. 4851-4856
Risultati: 1-6 |